Small molecule target deconvolution via cellular thermal shift assay

Ended Purchase Order Awarded

Contract number
75N95024P00283
Awardee
Awarding agency
Obligated
$63,800

Award facts

Opportunity
Contract value 100% obligated
$63,800.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541380 Testing Laboratories and Services
PSC
Q301 Reference Laboratory Testing
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Sweden

Award details come from SAM.gov/FPDS.

About this award

The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $63,800.00 firm fixed price purchase order contract to Pelago Bioscience AB, a for-profit limited liability company, to perform "Small Molecule Target Deconvolution via Cellular Thermal Shift Assay (CETSA)." This requirement was originally posted as a Sources Sought notice, seeking information on qualified sources to perform CETSA experiments, including sample preparation, mass spectrometry protein quantification, and data analysis. The period of performance is 12 months, with data delivery expected within 6 months of contract award. There was no set-aside designation mentioned for this procurement.

Quick answers

Who was awarded contract 75N95024P00283?

75N95024P00283 was awarded to Pelago Bioscience AB by National Institute on Drug Abuse (National Institutes of Health) on May 21, 2024.

How much is contract 75N95024P00283 worth?

The government has obligated $63,800 on 75N95024P00283.

Was contract 75N95024P00283 competed?

The extent of competition for 75N95024P00283 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award